Clinical Trials in North Carolina

Showing 8221-8240 of 15,496 trials

Scoring System for Inhalation Injury

NCT01194024

The goal of this multicenter study is to develop a standardized scoring system for inhalation injury that can be used both to quantify and predict injury severity inhalation injury in adults over 18 years of age. A model will be developed based on clinical, radiographic, bronchoscopic, and biochemical parameters that will predict the severity of inhalation injury with greater than 80% predictive accuracy

Inhalation Injury

American Burn Association108 participantsStarted Nov 2011

Phoenix, Arizona, United States • Little Rock, Arkansas, United States • Sacramento, California, United States +6 more locations

COMPLETEDPhase 3129 miles

A Long-term Safety Study of Olumacostat Glasaretil Gel in Subjects With Acne Vulgaris

NCT03127956

The objective of this study is to assess the long-term safety of Olumacostat Glasaretil gel, 5.0% in patients with acne vulgaris

Acne Vulgaris

Dermira, Inc.748 participantsStarted Mar 2017

Guntersville, Alabama, United States • Glendale, Arizona, United States • Phoenix, Arizona, United States +91 more locations

Scoring System for Inhalation Injury

A Long-term Safety Study of Olumacostat Glasaretil Gel in Subjects With Acne Vulgaris

Find Trials by Condition in North Carolina

Follow-up Study of Growth, Safety, and Efficacy of an Infant Formula for Healthy Term Infants

Clinical Outcomes in Patients Treated With SternaLock Blu

Efficacy and Safety of 26-Week Treatment of AR1001 in Patients With Mild to Moderate Alzheimer's Disease

A Phase 3, Long-term Safety and Tolerability Study of ALKS 3831 in Adults With Schizophrenia

Safety and Efficacy Study of Trans Sodium Crocetinate (TSC) in Newly Diagnosed Glioblastoma (GBM) Biopsy-Only Subjects

A Study of Olumacostat Glasaretil Gel in Subjects With Acne Vulgaris

A Study of Guselkumab in the Treatment of Participants With Moderate to Severe Plaque-Type Psoriasis With Randomized Withdrawal and Retreatment

A Phase 3 Randomized, Double-blind Study to Evaluate the Efficacy and Safety of Apremilast (CC-10004) in Subjects With Active Behçet's Disease

Phase 2/3 Study of IGSC, 20% in PIDD

A Study to Understand the Genetics and Clinical Course of Focal Segmental Glomerulosclerosis (FSGS), Treatment-Resistant Minimal Change Disease (TR-MCD), and Diabetic Nephropathy (DN)

Serum Concentrations of Pregnancy-associated Proteins for Assessment of Gestational Age Before Abortion

Natural History Study of MNGIE

An Extension Study to Determine the Safety and Anti-Leukemic Effects of Imatinib Mesylate in Adult Participants With Ph+ Leukemia

Study of IL-22 IgG2-Fc (F-652) for Subjects With Grade II-IV Lower GI aGVHD

A Study to Test the Safety and Effectiveness of Nivolumab Combined With Daratumumab in Patients With Pancreatic, Non-Small Cell Lung or Triple Negative Breast Cancers, That Have Advanced or Have Spread

Open Label Study of IV Brincidofovir in Adult Transplant Recipients With Adenovirus Viremia

Breast Mesh Used in Two-staged Breast Reconstruction

A Phase II Study of PDC-1421 Capsule to Evaluate the Safety and Efficacy in Patients With Major Depressive Disorder